OConnell Brendan 4
4 · MDxHealth SA · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
MDxHealth (MDXH) VP Finance Brendan O'Connell Receives Option Awards
What Happened
Brendan O'Connell, VP, Finance and Accounting of MDxHealth SA (MDXH), received option awards totaling 100,000 options on June 1, 2026. The Form 4 reports two derivative grants: 35,000 options and 65,000 options, each shown as acquired at $0.00 because these are stock-option grants (not share purchases). The options have an exercise price of $0.76 per share; no shares were sold or exercised in this filing and no cash changed hands at grant.
Key Details
- Transaction date(s): June 1, 2026; Form 4 filed June 3, 2026 (appears timely).
- Reported items: 35,000 option award (derivative) and 65,000 option award (derivative), exercise price $0.76 per share; entries listed as acquired at $0.00.
- Vesting: 35,000-options award is performance-based (vesting upon Board evaluation of specified performance criteria); 65,000-options award vests in three equal installments on each of the first three anniversaries of grant.
- Shares owned after transaction: not specified in the provided filing details.
- Filing timeliness: filing date (June 3) is within the Form 4 reporting window following the June 1 transaction (no late-filing flag noted).
Context
These are option grants (compensation awards), not purchases or sales. Options must be exercised (and any vesting conditions satisfied) before the holder acquires ordinary shares; this filing does not indicate any immediate sale of underlying shares. Such grants are common executive compensation and should be viewed as a company-issued award rather than a direct insider buy or sell signal.
Insider Transaction Report
- Award
Share Option
[F1]2026-06-01+35,000→ 35,000 totalExercise: $0.76Exp: 2035-06-27→ Ordinary Shares (35,000 underlying) - Award
Share Option
[F2]2026-06-01+65,000→ 65,000 totalExercise: $0.76Exp: 2035-06-27→ Ordinary Shares (65,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
- [F2]Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant.